ReP USP - Resultado da busca

Artigo de periodico
Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? (2023)
Zanetti, Maria Olívia Barboza; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, ADESÃO À MEDICAÇÃO, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 348-357, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073469. Acesso em: 02 jun. 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? Journal of Oncology Pharmacy Practice, 29( 2), 348-357. doi:10.1177/10781552211073469
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1177/10781552211073469
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1177/10781552211073469
Artigo de periodico
Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team (2023)
Zanetti, Maria Olívia Barboza; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, HOSPITALIZAÇÃO, SERVIÇOS FARMACÊUTICOS, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 375-385, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073797. Acesso em: 02 jun. 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29( 2), 375-385. doi:10.1177/10781552211073797
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1177/10781552211073797
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1177/10781552211073797
Artigo de periodico
Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients (2021)
Costa, Thalita Cristina de Mello; Chiari-Correia, Rodolfo; Salmon, Carlos Ernesto Garrido ; Darrigo-Junior, Luiz Guilherme; Grecco, Carlos Eduardo S; Pieroni, Fabiano; Faria, Joana Teresa B; Stracieri, Ana Beatriz P. L; Dias, Juliana B. E; Moraes, Daniela Aparecida de; Oliveira, Maria Carolina; Cunha, Renato Luiz Guerino; Santos, Antônio Carlos dos; Simões, Belinda Pinto
Source: Bone Marrow Transplantation. Unidades: FFCLRP, FMRP
Subjects: CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, GENÉTICA, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Thalita Cristina de Mello et al. Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients. Bone Marrow Transplantation, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41409-021-01365-z. Acesso em: 02 jun. 2024.
APA
Costa, T. C. de M., Chiari-Correia, R., Salmon, C. E. G., Darrigo-Junior, L. G., Grecco, C. E. S., Pieroni, F., et al. (2021). Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients. Bone Marrow Transplantation. doi:10.1038/s41409-021-01365-z
NLM
Costa TC de M, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, Grecco CES, Pieroni F, Faria JTB, Stracieri ABPL, Dias JBE, Moraes DA de, Oliveira MC, Cunha RLG, Santos AC dos, Simões BP. Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients [Internet]. Bone Marrow Transplantation. 2021 ;[citado 2024 jun. 02 ] Available from: https://doi.org/10.1038/s41409-021-01365-z
Vancouver
Costa TC de M, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, Grecco CES, Pieroni F, Faria JTB, Stracieri ABPL, Dias JBE, Moraes DA de, Oliveira MC, Cunha RLG, Santos AC dos, Simões BP. Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients [Internet]. Bone Marrow Transplantation. 2021 ;[citado 2024 jun. 02 ] Available from: https://doi.org/10.1038/s41409-021-01365-z
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 02 jun. 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party (2021)
Henes, Joerg; Oliveira, Maria Carolina; Labopin, Myriam; Badoglio, Manuela; Scherer, Hans Ulrich; Del Papa, Nicoletta; Daikeler, Thomas; Schmalzing, Marc; Schroers, Roland; Martin, Thierry; Pugnet, Gregory; Simões, Belinda Pinto; Michonneau, David; Marijt, Erik W. A.; Lioure, Bruno; Bay, Jacques Olivier; Snowden, John A.; Rovira, Montserrat; Huynh, Anne; Onida, Francesco; Kanz, Lothar; Marjanovic, Zora; Farge, Dominique
Source: Haematologica: the hematology journal. Unidade: FMRP
Subjects: ENVELHECIMENTO, DOENÇAS AUTOIMUNES, MEDULA ÓSSEA, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, ESTUDOS PROSPECTIVOS, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENES, Joerg et al. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica: the hematology journal, v. 106, n. 2, p. 375-383, 2021Tradução . . Disponível em: https://doi.org/10.3324/haematol.2019.230128. Acesso em: 02 jun. 2024.
APA
Henes, J., Oliveira, M. C., Labopin, M., Badoglio, M., Scherer, H. U., Del Papa, N., et al. (2021). Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica: the hematology journal, 106( 2), 375-383. doi:10.3324/haematol.2019.230128
NLM
Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T, Pugnet G, Simões BP, Michonneau D, Marijt EWA, Lioure B, Bay JO, Snowden JA, Rovira M, Huynh A, Onida F, Kanz L, Marjanovic Z, Farge D. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party [Internet]. Haematologica: the hematology journal. 2021 ; 106( 2): 375-383.[citado 2024 jun. 02 ] Available from: https://doi.org/10.3324/haematol.2019.230128
Vancouver
Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T, Pugnet G, Simões BP, Michonneau D, Marijt EWA, Lioure B, Bay JO, Snowden JA, Rovira M, Huynh A, Onida F, Kanz L, Marjanovic Z, Farge D. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party [Internet]. Haematologica: the hematology journal. 2021 ; 106( 2): 375-383.[citado 2024 jun. 02 ] Available from: https://doi.org/10.3324/haematol.2019.230128
Artigo de periodico
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? (2021)
Silveira, Douglas Rafaele Almeida; Coelho-Silva, Juan L.; Silva, Wellington Fernandes da; Vallance, Grant; Pereira-Martins, Diego A; Madeira, Maria I. A.; Figueredo-Pontes, Lorena L.; Velloso, Elvira Deolinda Rodrigues Pereira; Simões, Belinda Pinto; Peniket, Andy; Danby, Robert; Rego, Eduardo Magalhães; Vyas, Paresh; Traina, Fabiola; Bendit, Israel; Quek, Lynn; Rocha, Vanderson
Source: Leukemia and Lymphoma. Unidades: FMRP, FM
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTES, CÉLULAS-TRONCO, HEMATOPOESE, LEUCEMIA MIELOIDE AGUDA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Douglas Rafaele Almeida et al. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ?. Leukemia and Lymphoma, v. 62, n. 1, p. 147-157, 2021Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1827252. Acesso em: 02 jun. 2024.
APA
Silveira, D. R. A., Coelho-Silva, J. L., Silva, W. F. da, Vallance, G., Pereira-Martins, D. A., Madeira, M. I. A., et al. (2021). A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? Leukemia and Lymphoma, 62( 1), 147-157. doi:10.1080/10428194.2020.1827252
NLM
Silveira DRA, Coelho-Silva JL, Silva WF da, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? [Internet]. Leukemia and Lymphoma. 2021 ; 62( 1): 147-157.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1080/10428194.2020.1827252
Vancouver
Silveira DRA, Coelho-Silva JL, Silva WF da, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? [Internet]. Leukemia and Lymphoma. 2021 ; 62( 1): 147-157.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1080/10428194.2020.1827252
Artigo de periodico
GVHD-derived plasma as a priming strategy of mesenchymal stem cells (2020)
Silva-Carvalho, Amandda Évelin; Rodrigues, Leane Perim; Schiavinato, Josiane Lilian dos Santos ; Alborghetti, Marcos Rodrigo; Bettarello, Gustavo; Simões, Belinda Pinto ; Neves, Francisco de Assis Rocha; Panepucci, Rodrigo Alexandre; Carvalho, Juliana Lott de; Saldanha-Araujo, Felipe
Source: Stem Cell Research & Therapy. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, LINFÓCITOS, DOENÇA ENXERTO-HOSPEDEIRO, ADJUVANTES IMUNOLÓGICOS, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-CARVALHO, Amandda Évelin et al. GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, v. 11, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1186/s13287-020-01659-x. Acesso em: 02 jun. 2024.
APA
Silva-Carvalho, A. É., Rodrigues, L. P., Schiavinato, J. L. dos S., Alborghetti, M. R., Bettarello, G., Simões, B. P., et al. (2020). GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, 11, 1-12. doi:10.1186/s13287-020-01659-x
NLM
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1186/s13287-020-01659-x
Vancouver
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1186/s13287-020-01659-x
Artigo de periodico
Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients (2020)
Costa-Pereira, Karla R.; Moraes, Daniela Aparecida; Dias, Juliana Bernardes Elias; Garcia, Juliana Tomé; Oliveira-Cardoso, Érika Arantes de ; Zombrilli, Andréia Ferreira; Leopoldo, Vanessa; Costa, Thalita Melo; Simões, Belinda Pinto ; Oliveira, Maria Carolina
Source: JCR : Journal of Clinical Rheumatology. Unidades: FMRP, FFCLRP
Subjects: REUMATOLOGIA, TRANSPLANTES, CÉLULAS-TRONCO, QUALIDADE DE VIDA, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-PEREIRA, Karla R. et al. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients. JCR : Journal of Clinical Rheumatology, v. 26, n. 7S, p. S131-S138, 2020Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001117. Acesso em: 02 jun. 2024.
APA
Costa-Pereira, K. R., Moraes, D. A., Dias, J. B. E., Garcia, J. T., Oliveira-Cardoso, É. A. de, Zombrilli, A. F., et al. (2020). Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients. JCR : Journal of Clinical Rheumatology, 26( 7S), S131-S138. doi:10.1097/RHU.0000000000001117
NLM
Costa-Pereira KR, Moraes DA, Dias JBE, Garcia JT, Oliveira-Cardoso ÉA de, Zombrilli AF, Leopoldo V, Costa TM, Simões BP, Oliveira MC. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients [Internet]. JCR : Journal of Clinical Rheumatology. 2020 ; 26( 7S): S131-S138.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/RHU.0000000000001117
Vancouver
Costa-Pereira KR, Moraes DA, Dias JBE, Garcia JT, Oliveira-Cardoso ÉA de, Zombrilli AF, Leopoldo V, Costa TM, Simões BP, Oliveira MC. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients [Internet]. JCR : Journal of Clinical Rheumatology. 2020 ; 26( 7S): S131-S138.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/RHU.0000000000001117
Artigo de periodico
Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles (2020)
Branco, Thamyres; Oliveira, Lígia Franco; Palinkas, Marcelo ; Vasconcelos, Paulo Batista de ; Oliveira, Maria Carolina; Simões, Belinda Pinto ; Regalo, Isabela Hallak ; Siéssere, Selma ; Regalo, Simone Cecilio Hallak
Source: Prague Medical Report. Unidades: FORP, FMRP
Subjects: FORÇA DE MORDIDA, ELETROMIOGRAFIA, CÉLULAS-TRONCO, MÚSCULOS MASTIGATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANCO, Thamyres et al. Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles. Prague Medical Report, v. 121, n. 3, p. 163-171, 2020Tradução . . Disponível em: https://doi.org/10.14712/23362936.2020.15. Acesso em: 02 jun. 2024.
APA
Branco, T., Oliveira, L. F., Palinkas, M., Vasconcelos, P. B. de, Oliveira, M. C., Simões, B. P., et al. (2020). Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles. Prague Medical Report, 121( 3), 163-171. doi:10.14712/23362936.2020.15
NLM
Branco T, Oliveira LF, Palinkas M, Vasconcelos PB de, Oliveira MC, Simões BP, Regalo IH, Siéssere S, Regalo SCH. Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles [Internet]. Prague Medical Report. 2020 ; 121( 3): 163-171.[citado 2024 jun. 02 ] Available from: https://doi.org/10.14712/23362936.2020.15
Vancouver
Branco T, Oliveira LF, Palinkas M, Vasconcelos PB de, Oliveira MC, Simões BP, Regalo IH, Siéssere S, Regalo SCH. Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles [Internet]. Prague Medical Report. 2020 ; 121( 3): 163-171.[citado 2024 jun. 02 ] Available from: https://doi.org/10.14712/23362936.2020.15
Artigo de periodico
Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia (2020)
Arcuri, Leonardo Javier; Nabhan, Samir Kanaan; Cunha, Renato Luiz Guerino; Nichele, Samantha; Ribeiro, Andreza Alice Feitosa; Fernandes, Juliana Folloni; Daudt, Liane Esteves; Rodrigues, Ana Luiza Melo; Arrais-Rodrigues, Celso; Seber, Adriana; Simões, Belinda Pinto
Source: Biology of Blood and Marrow Transplantation. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ANEMIA, DOADORES DE SANGUE, HEMATOLOGIA, TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCURI, Leonardo Javier et al. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, v. 26, n. 12, p. 2311-2317, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.09.007. Acesso em: 02 jun. 2024.
APA
Arcuri, L. J., Nabhan, S. K., Cunha, R. L. G., Nichele, S., Ribeiro, A. A. F., Fernandes, J. F., et al. (2020). Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, 26( 12), 2311-2317. doi:10.1016/j.bbmt.2020.09.007
NLM
Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007
Vancouver
Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007
Tese (Doutorado)
Immunogenetics in sickle cell disease (2019)
Maio, Karina Tozatto; Simões, Belinda Pinto (Orientador)
Unidade: FMRP
Subjects: CÉLULAS-TRONCO, DOAÇÃO, INFECÇÕES BACTERIANAS, POLIMORFISMO, HEMOGLOBINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIO, Karina Tozatto. Immunogenetics in sickle cell disease. 2019. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2019. Disponível em: http://www.teses.usp.br/teses/disponiveis/17/17153/tde-17122019-151356/. Acesso em: 02 jun. 2024.
APA
Maio, K. T. (2019). Immunogenetics in sickle cell disease (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de http://www.teses.usp.br/teses/disponiveis/17/17153/tde-17122019-151356/
NLM
Maio KT. Immunogenetics in sickle cell disease [Internet]. 2019 ;[citado 2024 jun. 02 ] Available from: http://www.teses.usp.br/teses/disponiveis/17/17153/tde-17122019-151356/
Vancouver
Maio KT. Immunogenetics in sickle cell disease [Internet]. 2019 ;[citado 2024 jun. 02 ] Available from: http://www.teses.usp.br/teses/disponiveis/17/17153/tde-17122019-151356/
Artigo de periodico
Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis (2018)
Arruda, Lucas C. M. ; Lima-Júnior, João R.; Clave, Emmanuel; Moraes, Daniela A.; Douay, Corinne; Fournier, Isabelle; Moins-Teisserenc, Hélène; Covas, Dimas Tadeu ; Simões, Belinda Pinto ; Farge, Dominique; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de ; Oliveira, Maria Carolina
Source: Bone Marrow Transplantation. Unidades: FMRP, FCFRP
Subjects: TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas C. M. et al. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, v. 53, n. 10, p. 1319-1327, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41409-018-0162-0. Acesso em: 02 jun. 2024.
APA
Arruda, L. C. M., Lima-Júnior, J. R., Clave, E., Moraes, D. A., Douay, C., Fournier, I., et al. (2018). Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, 53( 10), 1319-1327. doi:10.1038/s41409-018-0162-0
NLM
Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1038/s41409-018-0162-0
Vancouver
Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1038/s41409-018-0162-0
Artigo de periodico
Serum cyclosporine levels: The influence of the time interval between interrupting the infusion and obtaining the samples: a randomized clinical trial (2018)
Garbin, Lívia Maria; Simões, Belinda Pinto; Curcioli, Ana Carolina de Jesus Vieira; Carvalho, Emilia Campos de
Source: Cancer Nursing. Unidades: EERP, FMRP
Subjects: CICLOSPORINAS, CATETERISMO VENOSO CENTRAL, RECEPTORES, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARBIN, Lívia Maria et al. Serum cyclosporine levels: The influence of the time interval between interrupting the infusion and obtaining the samples: a randomized clinical trial. Cancer Nursing, v. 41, n. 4, p. E55–E61, 2018Tradução . . Disponível em: https://doi.org/10.1097/NCC.0000000000000544. Acesso em: 02 jun. 2024.
APA
Garbin, L. M., Simões, B. P., Curcioli, A. C. de J. V., & Carvalho, E. C. de. (2018). Serum cyclosporine levels: The influence of the time interval between interrupting the infusion and obtaining the samples: a randomized clinical trial. Cancer Nursing, 41( 4), E55–E61. doi:10.1097/NCC.0000000000000544
NLM
Garbin LM, Simões BP, Curcioli AC de JV, Carvalho EC de. Serum cyclosporine levels: The influence of the time interval between interrupting the infusion and obtaining the samples: a randomized clinical trial [Internet]. Cancer Nursing. 2018 ; 41( 4): E55–E61.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/NCC.0000000000000544
Vancouver
Garbin LM, Simões BP, Curcioli AC de JV, Carvalho EC de. Serum cyclosporine levels: The influence of the time interval between interrupting the infusion and obtaining the samples: a randomized clinical trial [Internet]. Cancer Nursing. 2018 ; 41( 4): E55–E61.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/NCC.0000000000000544
Artigo de periodico
Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients (2018)
Arruda, Lucas C. M. ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Lima Júnior, João Rodrigues; Clave, Emmanuel; Dias, Juliana Bernardes Elias; Moraes, Daniela A.; Douay, Corinne; Fournier, Isabelle; Moins-Teisserenc, Hélène; Alberdi, Antônio José; Covas, Dimas Tadeu ; Simões, Belinda Pinto ; Lansiaux, Pauline; Oliveira, Maria Carolina
Source: Blood Advances. Unidades: FMRP, FCFRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, SISTEMA IMUNE, LINFÓCITOS T, TRANSPLANTE AUTÓLOGO, TIMO (GLÂNDULA ENDÓCRINA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas C. M. et al. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances, v. 2, n. 2, p. 126-141, 2018Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017011072. Acesso em: 02 jun. 2024.
APA
Arruda, L. C. M., Farias, K. C. R. M. de, Lima Júnior, J. R., Clave, E., Dias, J. B. E., Moraes, D. A., et al. (2018). Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances, 2( 2), 126-141. doi:10.1182/bloodadvances.2017011072
NLM
Arruda LCM, Farias KCRM de, Lima Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Oliveira MC. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [Internet]. Blood Advances. 2018 ; 2( 2): 126-141.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1182/bloodadvances.2017011072
Vancouver
Arruda LCM, Farias KCRM de, Lima Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Oliveira MC. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [Internet]. Blood Advances. 2018 ; 2( 2): 126-141.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1182/bloodadvances.2017011072
Artigo de periodico
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation (2018)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Tognon, Raquel ; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pontes, Lorena Lobo de Figueiredo ; Catto, Luiz Fernando Bazzo ; Traina, Fabiola ; Souto, Elizabeth Xisto; Zambuzi, Fabiana Albani ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Source: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, INFLAMAÇÃO, CITOCINAS, CÉLULAS MIELOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematology, Transfusion and Cell Therapy, v. 40, n. 2, p. 120-131, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2017.12.003. Acesso em: 02 jun. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Tognon, R., Nunes, N. de S., Simões, B. P., Pontes, L. L. de F., et al. (2018). Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematology, Transfusion and Cell Therapy, 40( 2), 120-131. doi:10.1016/j.htct.2017.12.003
NLM
Cacemiro M da C, Cominal JG, Tognon R, Nunes N de S, Simões BP, Pontes LL de F, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 2): 120-131.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1016/j.htct.2017.12.003
Vancouver
Cacemiro M da C, Cominal JG, Tognon R, Nunes N de S, Simões BP, Pontes LL de F, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 2): 120-131.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1016/j.htct.2017.12.003
Artigo de periodico
Impact of ABO-mismatch on outcome in bone marrow transplantation (2018)
De Santis, G. C.; Malta, R. O.; Garcia-Silva, A. C.; Prata, K. de L.; Oliveira, Maria Carolina de; Moraes, D. A. de; Stracieri, A. B. P.; Pieroni, F.; Martinez, Edson Zangiacomi; Simões, Belinda Pinto; Covas, Dimas Tadeu
Source: ISBT Science Series. Unidade: FMRP
Subjects: GRUPOS SANGUÍNEOS, TRANSFUSÃO DE SANGUE, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, G. C. et al. Impact of ABO-mismatch on outcome in bone marrow transplantation. ISBT Science Series, v. 13, n. 2, p. 158-164, 2018Tradução . . Disponível em: https://doi.org/10.1111/voxs.12371. Acesso em: 02 jun. 2024.
APA
De Santis, G. C., Malta, R. O., Garcia-Silva, A. C., Prata, K. de L., Oliveira, M. C. de, Moraes, D. A. de, et al. (2018). Impact of ABO-mismatch on outcome in bone marrow transplantation. ISBT Science Series, 13( 2), 158-164. doi:10.1111/voxs.12371
NLM
De Santis GC, Malta RO, Garcia-Silva AC, Prata K de L, Oliveira MC de, Moraes DA de, Stracieri ABP, Pieroni F, Martinez EZ, Simões BP, Covas DT. Impact of ABO-mismatch on outcome in bone marrow transplantation [Internet]. ISBT Science Series. 2018 ; 13( 2): 158-164.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1111/voxs.12371
Vancouver
De Santis GC, Malta RO, Garcia-Silva AC, Prata K de L, Oliveira MC de, Moraes DA de, Stracieri ABP, Pieroni F, Martinez EZ, Simões BP, Covas DT. Impact of ABO-mismatch on outcome in bone marrow transplantation [Internet]. ISBT Science Series. 2018 ; 13( 2): 158-164.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1111/voxs.12371
Trabalho de evento-resumo
Monitoramento de quimerismo hematopoiético por marcadores inserção/deleção (2017)
Santos, M. D.; Simões, Belinda Pinto; Simões, Aguinaldo Luiz
Source: Resumos. Conference titles: Workshop do Programa de Pós-Graduação em Genética da FMRP-USP. Unidade: FMRP
Subjects: DELEÇÃO DE GENES, CÉLULAS-TRONCO, HEMATOPOESE, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, M. D. e SIMÕES, Belinda Pinto e SIMÕES, Aguinaldo Luiz. Monitoramento de quimerismo hematopoiético por marcadores inserção/deleção. 2017, Anais.. Ribeirão Preto: FMRP-USP, 2017. . Acesso em: 02 jun. 2024.
APA
Santos, M. D., Simões, B. P., & Simões, A. L. (2017). Monitoramento de quimerismo hematopoiético por marcadores inserção/deleção. In Resumos. Ribeirão Preto: FMRP-USP.
NLM
Santos MD, Simões BP, Simões AL. Monitoramento de quimerismo hematopoiético por marcadores inserção/deleção. Resumos. 2017 ;[citado 2024 jun. 02 ]
Vancouver
Santos MD, Simões BP, Simões AL. Monitoramento de quimerismo hematopoiético por marcadores inserção/deleção. Resumos. 2017 ;[citado 2024 jun. 02 ]
Artigo de periodico
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation (2017)
Dotoli, G. M.; Santis, G. C. de; Orellana, M. D.; Prata, K. de Lima; Caruso, S. R.; Fernandes, T. R.; Colturato, V. A. Rensi; Kondo, A. T.; Hamerschlak, N.; Simões, Belinda Pinto; Covas, Dimas Tadeu
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: LEUCEMIA, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOTOLI, G. M. et al. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation. Bone Marrow Transplantation, v. 52, n. 6, p. 859-862, 2017Tradução . . Disponível em: https://doi.org/10.1038/bmt.2017.35. Acesso em: 02 jun. 2024.
APA
Dotoli, G. M., Santis, G. C. de, Orellana, M. D., Prata, K. de L., Caruso, S. R., Fernandes, T. R., et al. (2017). Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 52( 6), 859-862. doi:10.1038/bmt.2017.35
NLM
Dotoli GM, Santis GC de, Orellana MD, Prata K de L, Caruso SR, Fernandes TR, Colturato VAR, Kondo AT, Hamerschlak N, Simões BP, Covas DT. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation [Internet]. Bone Marrow Transplantation. 2017 ; 52( 6): 859-862.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1038/bmt.2017.35
Vancouver
Dotoli GM, Santis GC de, Orellana MD, Prata K de L, Caruso SR, Fernandes TR, Colturato VAR, Kondo AT, Hamerschlak N, Simões BP, Covas DT. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation [Internet]. Bone Marrow Transplantation. 2017 ; 52( 6): 859-862.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1038/bmt.2017.35
Artigo de periodico
Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis (2017)
Muraro, Paolo A.; Pasquini, Marcelo; Atkins, Harold L.; Bowen, James D.; Farge, Dominique; Fassas, Athanasios; Freedman, Mark S.; Georges, George E.; Gualandi, Francesca; Simões, Belinda Pinto
Source: JAMA Neurology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURARO, Paolo A. et al. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology, v. 74, n. 4, p. 459-469, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaneurol.2016.5867. Acesso em: 02 jun. 2024.
APA
Muraro, P. A., Pasquini, M., Atkins, H. L., Bowen, J. D., Farge, D., Fassas, A., et al. (2017). Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology, 74( 4), 459-469. doi:10.1001/jamaneurol.2016.5867
NLM
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Simões BP. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. JAMA Neurology. 2017 ; 74( 4): 459-469.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1001/jamaneurol.2016.5867
Vancouver
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Simões BP. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. JAMA Neurology. 2017 ; 74( 4): 459-469.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1001/jamaneurol.2016.5867
Artigo de periodico
Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies (2017)
Pereira, Bárbara Brito de Souza; Darrigo Júnior, Luiz Guilherme; Costa, Thalita Cristina de Mello; Felix, Alvina Clara; Simões, Belinda Pinto; Stracieri, Ana Beatriz; Silva, Paula Moreira da; Mauad, Marcos; Machado, Clarisse Martins
Source: Transplant Infectious Disease. Unidades: IMT, FMRP
Subjects: VÍRUS DA DENGUE, HEMATOLOGIA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Bárbara Brito de Souza et al. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transplant Infectious Disease, v. 19, n. 4, p. e12721 (5 ), 2017Tradução . . Disponível em: https://doi.org/10.1111/tid.12721. Acesso em: 02 jun. 2024.
APA
Pereira, B. B. de S., Darrigo Júnior, L. G., Costa, T. C. de M., Felix, A. C., Simões, B. P., Stracieri, A. B., et al. (2017). Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transplant Infectious Disease, 19( 4), e12721 (5 ). doi:10.1111/tid.12721
NLM
Pereira BB de S, Darrigo Júnior LG, Costa TC de M, Felix AC, Simões BP, Stracieri AB, Silva PM da, Mauad M, Machado CM. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies [Internet]. Transplant Infectious Disease. 2017 ; 19( 4): e12721 (5 ).[citado 2024 jun. 02 ] Available from: https://doi.org/10.1111/tid.12721
Vancouver
Pereira BB de S, Darrigo Júnior LG, Costa TC de M, Felix AC, Simões BP, Stracieri AB, Silva PM da, Mauad M, Machado CM. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies [Internet]. Transplant Infectious Disease. 2017 ; 19( 4): e12721 (5 ).[citado 2024 jun. 02 ] Available from: https://doi.org/10.1111/tid.12721

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration